Imaging of extranodal lymphoma with PET/CT

Clinical Nuclear Medicine

Volumn 36, Issue 10, 2011, Pages

  Ilica, Ahmet Turan ^a   Kocacelebi, Kenan ^b   Savas, Recep ^c   Ayan, Asli ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

^b Ege Saglik Hastanesi   (Turkey)

^c EGE UNIVERSITY   (Turkey)

Author keywords

Extranodal lymphoma; PET CT

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

BONE MARROW TUMOR; BRAIN LYMPHOMA; BRAIN TUMOR; BREAST TUMOR; CANCER DIAGNOSIS; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ERROR; DIAGNOSTIC VALUE; DISEASE SEVERITY; EXTRANODAL LYMPHOMA; HEAD AND NECK TUMOR; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; INTERSTITIAL PNEUMONIA; INTESTINE LYMPHOMA; LYMPHADENOPATHY; LYMPHOMA; MAMMOGRAPHY; MUSCULOSKELETAL DISEASE; NONHODGKIN LYMPHOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; ORBIT TUMOR; PANCREAS TUMOR; PLEURA EFFUSION; POSITRON EMISSION TOMOGRAPHY; REVIEW; SALIVARY GLAND TUMOR; SKIN LYMPHOMA; STOMACH LYMPHOMA; ULCER;

HODGKIN DISEASE; HUMANS; LYMPH NODES; LYMPHOMA; LYMPHOMA, NON-HODGKIN; ORGAN SPECIFICITY; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY;

EID: 80053585742     PISSN: 03639762     EISSN: 15360229     Source Type: Journal    
DOI: 10.1097/RLU.0b013e31821c99cd     Document Type: Review

References (77)

1. Rodríguez-Vigil B, Gómez-León N, Pinilla I, et al. Positron emission tomography/computed tomography in the management of Hodgkin's disease and non-Hodgkin's lymphoma [review]. Probl Diagn Radiol. 2006;35:151-163. (Pubitemid 43923542)
2. Freeman C, Berg JW, Cutler SJ. Occurrence and prognosis of extranodal lymphomas. Cancer. 1972;39:252-260.
3. Chua SC, Rozalli FI, O'Connor SR. Imaging features of primary extranodal lymphomas. Clin Radiol. 2009;64:574-588.
4. Zucca E, Conconi A, Cavalli F. Treatment of extranodal lymphomas. Best Pract Res Clin Haematol. 2002;15:533-547.
5. Hasenclever D, Diehl V. A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease. N Engl J Med. 1998;339:1506-1514. (Pubitemid 28543499)
6. Kostakoglu L. 18F-Fluorodeoxyglucose positron emission tomography in the management of lymphomas. Clin Lymphoma Myeloma. 2008;8:273-276.
7. Economopoulos T, Asprou N, Stathakis N, et al. Primary extranodal non-Hodgkin's lymphoma in adults: clinicopathological and survival characteristics. Leuk Lymphoma. 1996;21:131-136. (Pubitemid 26059014)
8. Even-Sapir E, Lievshitz G, Perry C, et al. Fluorine-18 fluorodeoxyglucose PET/CT patterns of extranodal involvement in patients with Non-Hodgkin lymphoma and Hodgkin's disease. Radiol Clin North Am. 2007;45:697-709. (Pubitemid 47238394)
9. Maes B, De Wolf-Peeters C. Marginal zone cell lymphoma-an update on recent advances. Histopathology. 2002;40:117-126. (Pubitemid 34122113)
10. Paes FM, Kalkanis DG, Sideras PA, Serafini AN. FDG PET/CT of extranodal involvement in non-Hodgkin lymphoma and Hodgkin disease. Radiographics. 2010;30:269-291.
11. Guermazi A, Brice P, de Kerviler EE, et al. Extranodal Hodgkin disease: spectrum of disease. Radiographics. 2001;21:161-179. (Pubitemid 33707416)
12. Ping L. Staging and classification of lymphoma. Semin Nucl Med. 2005;35: 160-164.
13. Rodríguez-Vigil B, Gómez-León N, Pinilla I, et al. Positron emission tomography/computed tomography in the management of Hodgkin's disease and non-Hodgkin's lymphoma. Curr Probl Diagn Radiol. 2006;35:151-163. (Pubitemid 43923542)
14. Jhanwar YS, Straus DJ. The role of PET in lymphoma. J Nucl Med. 2006;47:1326-1334. (Pubitemid 47544887)
15. Kwee TC, Kwee RM, Nievelstein RA. Imaging in staging of malignant lymphoma: a systematic review. Blood. 2008;111:504-516.
16. Moog F, Bangerter M, Diederichs CG, et al. Extranodal malignant lymphoma: detection with FDG PET versus CT. Radiology. 1998;206:475-481. (Pubitemid 28112964)
17. Israel O, Keidar Z, Bar-Shalom R. Positron emission tomography in the evaluation of lymphoma. Semin Nucl Med. 2004;34:166-179. (Pubitemid 38887173)
18. Raanani P, Shasha Y, Perry C, et al. Is CT scan still necessary for staging in Hodgkin and non-Hodgkin lymphoma patients in the PET/CT era? Ann Oncol. 2006;17:117-122. (Pubitemid 43033850)
19. Metser U, Goor O, Lerman H, et al. PET-CT of extranodal lymphoma. Am J Roentgenol. 2004;182:1579-1586. (Pubitemid 38668869)
20. Osborn A. Brain tumors and tumor-like processes. In: Osborn A, ed. Diagnostic Neuroradiology. St Louis, MO: Mosby; 1994:401-529.
21. Karantanis D, O'Neill BP, Subramaniam RM, et al. Contribution of F-18 FDG PET-CT in the detection of systemic spread of primary central nervous system lymphoma. Clin Nucl Med. 2007;32:271-274. (Pubitemid 46569310)
22. Soussan M, Warski M, Erza J, et al. Non-Hodgkin lymphoma localization in the pituitary gland diagnosis by FDG-PET/CT. Clin Nucl Med. 2008;33:111-112.
23. Haque S, Law M, Abrey LE, et al. Imaging of lymphoma of the central nervous system, spine, and orbit. Radiol Clin North Am. 2008;46:339-361. (Pubitemid 351932047)
24. Metser U, Lerman H, Blank A, et al. Malignant involvement of the spine: assessment by 18F-FDG PET/CT. J Nucl Med. 2004;45:279-284. (Pubitemid 47618649)
25. Kanter P, Zeidman A, Streifler J, et al. PET-CT imaging of combined brachial and lumbosacral neurolymphomatosis. Eur J Haematol. 2005;74:66-69. (Pubitemid 40143689)
26. Bokstein F, Goor O, Shihman B, et al. Assessment of neurolymphomatosis by brachial plexus biopsy and PET/CT. Report of a case. J Neurooncol. 2005; 72:163-167. (Pubitemid 40796467)
27. Ho L, Valenzuela D, Negahban A, et al. Primary spinal epidural non-Hodgkin lymphoma demonstrated by FDG PET/CT. Clin Nucl Med. 2010;35:487-489.
28. Dong Q, Wong KK, Avram AM. Sacral nerve root neurolymphomatosis diagnosed on FDG-PET/CT and magnetic resonance imaging. Clin Nucl Med. 2008;33:30-31.
29. Rosenberg SA, eds. Cancer: Principles and Practice Of Oncology. Philadelphia, Lippincott Williams & Wilkins; 2001:2300-2316.
30. Gill MK, Jampol LM. Variations in the presentation of primary intraocular lymphoma case reports and a review. Surv Ophthalmol. 2001;45:463-471.
31. Sullivan TJ, Valenzuela AA. Imaging features of ocular adnexal lymphoproliferative disease. Eye. 2006;20:1189-1195. (Pubitemid 44515581)
32. Valenzuela AA, Allen C, Grimes D, et al. Positron emission tomography in the detection and staging of ocular adnexal lymphoproliferative disease. Ophthalmology. 2006;113:2331-2337. (Pubitemid 44848369)
33. Suga K, Yasuhiko K, Hiyama A, et al. F-18 FDG PET/CT findings in a patient with bilateral orbital and gastric mucosa-associated lymphoid tissue lymphomas. Clin Nucl Med. 2009;34:589-593.
34. Lee YY, Van Tassel P, Nauert C, et al. Lymphomas of the head and neck: CT findings at initial presentation. Am J Roentgenol. 1987;149:575-581. (Pubitemid 17145151)
35. Zhang MJ, Jiang JJ, Jiang MS, et al. F-18 FDG PET/CT in Primary Tonsillar Lymphoma. Clin Nucl Med. 2010;35:710-712.
36. Karantanis D, Subramaniam RM, Peller PJ, et al. The value of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in extranodal natural killer/T-cell lymphoma. Clin Lymphoma Myeloma. 2008;8:94-99. (Pubitemid 351775766)
37. Nakamoto Y, Tatsumi M, Hammoud D, et al. Normal FDG distribution patterns in the head and neck: PET/CT evaluation. Radiology. 2005;234:879-885. (Pubitemid 40250832)
38. Subhash C, Alkis PZ, David AB, et al. Positron emission tomography in primary thyroid lymphoma. Clin Nucl Med. 2004;29:572-573.
39. Eugene CL. FDG PET/CT for assessing therapy response in primary thyroid lymphoma. Clin Nucl Med. 2007;32:152-153.
40. Weijs LE, Arsos G, Baarslag HJ, et al. Pericardial involvement in a non- Hodgkin lymphoma patient: coregistered FDG PET and CT imaging. Eur Heart J. 2007;28:2698. (Pubitemid 350135525)
41. Kaderli AA, Baran I, Aydin O, et al. Diffuse involvement of the heart and great vessels in primary cardiac lymphoma. Eur J Echocardiogr. 2010;11: 74-76.
42. Ferdinand B, Gupta P, Kramer EL. Spectrum of thymic uptake at 18F-FDG PET. Radiographics. 2004;24:1611-1616. (Pubitemid 39611120)
43. Bae YA, Lee KS. Cross-sectional evaluation of thoracic lymphoma. Radiol Clin North Am. 2008;46:253-264. (Pubitemid 351932044)
44. Nihashi T, Hayasaka K, Itou T, et al. Findings of fluorine-18-FDG PET in extranodal origin lymphoma in three cases of diffuse large B cell type lymphoma. Ann Nucl Med. 2006;20:689-693. (Pubitemid 46155204)
45. Yang WT, Lane DL, Le-Petross HT, et al. Breast lymphoma: imaging findings of 32 tumors in 27 patients. Radiology. 2007;245:692-702. (Pubitemid 350127339)
46. Ghai S, Pattison J, O'Malley ME, et al. Primary gastrointestinal lymphoma: spectrum of imaging findings with pathologic correlation. Radiographics. 2007;27:1371-1388.
47. Kumar R, Xiu Y, Dhurairaj T, et al. F-18 FDG positron emission tomography in non-Hodgkin lymphoma of the breast. Clin Nucl Med. 2005;30:246-248. (Pubitemid 40396821)
48. Miller FH, Kochman ML, Talamonti MS, et al. Gastric cancer: radiologic staging. Radiol Clin North Am. 1997;35:331-349. (Pubitemid 27142424)
49. Juweid ME, Stroobants S, Hoekstra OS, et al. Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma. J Clin Oncol. 2007;25:571-578. (Pubitemid 350002965)
50. Radan L, Fischer D, Bar-Shalom R, et al. FDG avidity and PET/CT patterns in primary gastric lymphoma. Eur J Nucl Med Mol Imaging. 2008;35:1424-1430.
51. Sam JW, Levine MS, Farner MC, et al. Detection of small bowel involvement by mantle cell lymphoma on F-18 FDG positron emission tomography. J Clin Oncol. 2000;18:795-803.
52. Mendelson RM, Fermoyle S. Primary gastrointestinal lymphomas: a radiological- pathological review. Part 1: Stomach, esophagus and colon. Australas Radiol. 2005;49:353-364.
53. Kumar R, Xiu Y, Potenta S, et al. 18F-FDG PET for evaluation of the treatment response in patients with gastrointestinal tract lymphomas. J Nucl Med. 2004;45:1796-803. (Pubitemid 47618434)
54. Fishman EK, Kuhlman JE, Jones RJ. CT of lymphoma: spectrum of disease. Radiographics. 1991;11:647-669.
55. Brant WE. Pancreas and spleen. In: Brant WE, Helms CA, eds. Fundamentals of Diagnostic Radiology. New York, NY: Lippincott Williams & Wilkins; 2006:691-706.
56. Fishman EK, Kuhlman JE, Jones RJ. CT of lymphoma: spectrum of disease. Radiographics. 1991;11:647-669.
57. Rini JN, Leonidas JC, Tomas MB, et al. 18F-FDG PET versus CT for evaluating the spleen during initial staging of lymphoma. J Nucl Med. 2003;44:1072-1074.
58. Fumika T, Hayato K, Masatoshi I, et al. Primary splenic lymphoma detected by F-18 FDG PET. Clin Nucl Med. 2008;33:204-207.
59. Baylor SM, Berg JW. Cross-classification and survival characteristics of 5000 cases of cancer of the pancreas. J Surg Oncol. 1973;5:335-358.
60. Behrns KE, Sarr MG, Strickler JG. Pancreatic lymphoma: is it a surgical disease? Pancreas. 1994;9:662-667. (Pubitemid 24276960)
61. Kumar R, Xiu Y, Mavi A, et al. FDG-PET imaging in primary bilateral adrenal lymphoma: a case report and review of the literature. Clin Nucl Med. 2005;30:222-230. (Pubitemid 40396815)
62. Charnsangavej C. Lymphoma of the genitourinary tract. Radiol Clin North Am. 1990;28:865-877. (Pubitemid 20181947)
63. Sharma A, Singh A. Primary lymphoma of urinary bladder: report of an unusual case and literature review. Internet J Urol. 2002;1.
64. Tasu JP, Geffroy D, Rocher L, et al. Primary malignant lymphoma of the urinary bladder: report of three cases and review of the literature. Eur Radiol. 2000;10:1261-1264.
65. Armitage JO, Mauch PM, Harris NL. Lymphomas: extranodal sites. In: DeVita VT, eds. Cancer: Principles and Practice of Oncology. Philadelphia, PA: Lippincott Williams & Wilkins; 2001:2300-2316.
66. Taheri MR, Dighe MK, Kolokythas O, et al. Multifaceted genitourinary lymphoma. Curr Probl Diagn Radiol. 2008;37:80-93. (Pubitemid 351256387)
67. Ferrozzi F, Catanese C, Uccelli M, et al. Ovarian lymphoma. Findings with ultrasonography, computerized tomography, and magnetic resonance. Radiol Med. 1998;95:493-497.
68. Carr I, Hill AS, Hancock B, et al. Malignant lymphoma of the cervix uteri: histology and ultrastructure. J Clin Pathol. 1976;29:680-686.
69. Lathrop JC. Malignant pelvic lymphomas. Obstet Gynecol. 1967;30:137-145.
70. Kazama T, Faria SC, Varavithya V, et al. FDG PET in the evaluation of treatment for lymphoma: clinical usefulness and pitfalls. Radiographics. 2005;25:191-207. (Pubitemid 40186951)
71. Krishnan A, Shirkhoda A, Tehranzadeh J, et al. Primary bone lymphoma: radiographic MR imaging correlation. Radiographics. 2003;23:1371-83. (Pubitemid 37487513)
72. Hermann G, Klein MJ, Abdelwahab IF, et al. MRI appearance of primary non-Hodgkin's lymphoma of bone. Skeletal Radiol. 1997;26:629-632. (Pubitemid 27511159)
73. Moog F, Kotzerke J, Reske SN. FDG PET can replace bone scintigraphy in primary staging of malignant lymphoma. J Nucl Med. 1999;40:1407-1413. (Pubitemid 29428919)
74. Pelosi E, Penna D, Deandreis D, et al. FDG PET in the detection of bone marrow disease in Hodgkin's disease and aggressive non-Hodgkin's lymphoma and its impact on clinical management. Q J Nucl Med Mol Imaging. 2008;52:9-16. (Pubitemid 351351040)
75. Park YH, Choi SJ, Ryoo BY, et al. PET imaging with F-18 fluorodeoxyglucose for primary lymphoma of bone. Clin Nucl Med. 2005;30:131-134. (Pubitemid 40116945)
76. Komatsuda M, Nagao T, Arimori S. An autopsy case of malignant lymphoma associated with remarkable infiltration in skeletal muscles. Rinsho Ketsueki. 1981;22:891-895.
77. Bishu S, Quigley JM, Schmitz J, et al. F-18-fluoro-deoxy-glucose positron emission tomography in the assessment of peripheral T-cell lymphomas. Leuk Lymphoma. 2007;48:1531-1538. (Pubitemid 47272803)